Orient Pharma Co., Ltd. (TPEX:4166)
Taiwan · Delayed Price · Currency is TWD 26.25
-0.70 (-2.60%)
Mar 26, 2026, 1:30 PM CST
Orient Pharma Market Cap
Orient Pharma has a market cap or net worth of 6.38 billion as of March 26, 2026. Its market cap has decreased by -24.33% in one year.
Market Cap
6.38B
Enterprise Value
5.95B
Revenue
1.40B
Ranking
n/a
PE Ratio
29.17
Stock Price
26.25
Market Cap Chart
Since June 15, 2012, Orient Pharma's market cap has increased from 4.12B to 6.38B, an increase of 55.00%. That is a compound annual growth rate of 3.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 6.55B | 3.06% |
| Dec 31, 2025 | 6.36B | -20.85% |
| Dec 31, 2024 | 8.03B | 80.00% |
| Dec 29, 2023 | 4.46B | 14.13% |
| Dec 30, 2022 | 3.91B | 11.76% |
| Dec 30, 2021 | 3.50B | 28.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foresee Pharmaceuticals | 12.10B |
| Standard Chemical & Pharmaceutical | 11.06B |
| Alar Pharmaceuticals | 11.06B |
| Handa Pharmaceuticals | 10.98B |
| Formosa Laboratories | 6.67B |
| SCI Pharmtech | 6.19B |
| LIWANLI Innovation | 5.75B |
| Easywell Biomedicals | 4.49B |